MarketPeel
Insider Trading Intelligence
Pricing
…
DY

David Young

PCSA
PRES. RESEARCH & DEVELOPMENT · PROCESSA PHARMACEUTICALS, INC. · CIK 0001378166
FILING MIX · LIFETIME86%/14%
BUYS
50
SELLS
8
TOTAL VALUE
$490.2K
COMPANIES
1
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
21,729
AVG SELL PX
$1.48
TRADE KIND
SHOWING 58 / 58
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 12 pending
Forward-return performance of every backtestable P/S trade by David Young, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+83.33%+6.83%+0.77%+6.07%+6.82%—
14d12+83.33%+6.86%+1.21%+5.66%+5.26%—
30d12+58.33%+8.50%+2.83%+6.91%-3.58%—
60d12+58.33%+8.67%+3.74%+5.60%+11.95%—
90d12(2 pending)+40.00%-11.92%+5.42%-17.35%-6.61%—
180d12(3 pending)+11.11%-40.21%+6.35%-46.57%-60.95%—
1y12(3 pending)+0.00%-78.02%+20.77%-98.79%-107.30%—
2y12(4 pending)+0.00%-96.50%+32.66%-129.16%-131.66%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PCSA · 21,729 shares · as of Jun 30, 2026
0455,254910,5081,365,7621,821,01620222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 50 buys / 8 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
2,531$1.93$4.9K21,729Jun 30, 2026Jul 1, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
2,067$2.22$4.6K19,198Jun 15, 2026Jun 16, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
1,786$2.57$4.6K17,131May 29, 2026Jun 1, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
1,545$2.97$4.6K15,345May 15, 2026May 19, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
1,706$2.69$4.6K13,813Apr 30, 2026May 1, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
1,545$2.97$4.6K12,107Apr 15, 2026Apr 17, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
1,810$2.54$4.6K10,562Mar 31, 2026Apr 1, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Pres. Research & Development
49——0Jan 1, 2026Feb 4, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
49——8,752Jan 1, 2026Feb 4, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
333,000——333,000Oct 1, 2025Oct 3, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
111,000——111,000Oct 1, 2025Oct 3, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,813,133——1,821,016Jul 24, 2025Jul 28, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
17,272——222,677Apr 1, 2025Apr 11, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Pres. Research & Development
5,345$0.41$2.2K217,332Apr 1, 2025Apr 11, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
124,500——124,500Jan 29, 2025Feb 18, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
62,250——62,250Jan 29, 2025Feb 18, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
124,500$0.80$99.3K205,405Jan 27, 2025Jan 29, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
644——81,187Jul 10, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Pres. Research & Development
282$1.71$48280,905Jul 10, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
404——25,155Jun 28, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,233——21,922Jun 28, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
404——24,751Jun 28, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,425——24,347Jun 28, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Pres. Research & Development
518$2.79$1.4K80,543Apr 5, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
1,675——81,061Apr 5, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
21,000$2.45$51.5K79,387Feb 7, 2024Feb 8, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
20,000$2.53$50.5K58,387Feb 6, 2024Feb 7, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Pres. Research & Development
518$2.79$1.4K80,544Jan 1, 2024Apr 12, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Pres. Research & Development
1,675——19,333Jan 1, 2024Apr 12, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Pres. Research & Development
1,675——81,062Jan 1, 2024Apr 12, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
155,277$0.29$45.0K767,701Oct 12, 2023Oct 12, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
142,000$0.24$34.1K612,424Oct 10, 2023Oct 10, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
President & CEO
40,000$0.80$32.0K470,424Jun 12, 2023Jun 12, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
President & CEO
20,000$0.55$11.0K430,424Apr 14, 2023Apr 14, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
President & CEO
20,000$0.48$9.6K410,424Apr 13, 2023Apr 13, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
President & CEO
20,000$0.45$9.0K390,424Apr 12, 2023Apr 13, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
President & CEO
20,000$0.52$10.4K370,424Apr 11, 2023Apr 13, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
18,750$0.80$15.0K350,424Feb 9, 2023Feb 10, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
24,030——424,373Jan 1, 2023Jan 4, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,350——400,343Dec 31, 2022Jan 4, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,350——374,993Sep 30, 2022Oct 3, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALEGRANT
Gift
9,250——377,784Aug 16, 2022Aug 23, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
President & CEO
7,601——389,565Aug 5, 2022Aug 9, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
President & CEO
2,531$3.17$8.0K387,034Aug 5, 2022Aug 9, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
46,877——349,643Jun 30, 2022Jul 5, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
247,841——302,766Apr 1, 2022Apr 11, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,715——37,781Mar 31, 2022Apr 4, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
6,722——6,722Dec 31, 2021Jan 4, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
6,722——22,780Dec 31, 2021Jan 6, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,286——27,066Nov 1, 2021Apr 4, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
6,024——16,058Sep 30, 2021Jan 6, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
6,024——6,024Sep 30, 2021Oct 4, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
7,601——381,964Aug 5, 2021Aug 9, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
8,572——8,572Jul 8, 2021Jul 9, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,907——10,034Jul 8, 2021Jul 9, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,858——12,858Jul 8, 2021Jul 9, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Executive Officer
10,000$7.67$76.7K345,190Jun 23, 2021Jun 23, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
8,127——8,127Jun 8, 2021Jun 10, 2021 ↗View →
Other insiders · PCSA
Loading peer insiders…
About this filer
CIK 0001378166
ROLE
Pres. Research & Development
PRIMARY
PCSA
COMPANIES
1
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001378166DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback